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1682-606X/Copyright ª 2014, TaiwanSummary Malignant melanoma of the anal canal is a rare, but aggressive, tumor with a poor
prognosis. It represents less than 1% of all melanomas and 4% of anorectal tumors. We are re-
porting this case because of its rarity in men and because, in this instance, the tumor was mis-
diagnosed as prolapsed thrombosed hemorrhoids and excised. Examination showed a visible
exophytic irreducible growth measuring about 3  3 cm and protruding outside the anal verge
and involving the anterior two-thirds of the circumference of the anal canal. A biopsy sample
showed round to oval cells with prominent nucleoli and marked intracytoplasmic pigmenta-
tion. A magnetic resonance imaging scan showed a tumor with nearly complete luminal
obstruction and liver metastasis. The patient received chemotherapy and radiotherapy, but
the response was very poor and he died 2 months later.
Copyright ª 2014, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Melanoma of the anal canal is an uncommon but highly
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Surgical Association. Published by4% of anorectal tumors other than adenocarcinoma.1 It has
an unfavorable prognosis with a predilection for early
infiltration and distant spread, resulting in poor overall
survival.2 These tumors commonly originate from the
squamous epithelium of the anal canal or the squamo-
columnar junction. About 0.4e1.6% of all melanomas
arise in the anorectal region and the anal canal is the most
frequent site for melanomas after the skin and retina.3 It is
more common in women and approximately 500 cases have
been reported previously.3e5 Melanoma of the anal canalElsevier Taiwan LLC. All rights reserved.
Figure 1 (A) Protruding anal mass with bluish black spots shown by black arrow. (B) Histological examination showed sheets of
cells with intracytoplasmic pigmentation. (C) Abdominal sonography showed multiple intrahepatic mixed echogenic lesions with
central necrosis.
Misdiagnosed anal canal melanoma 75usually occurs below the dentate line, although it some-
times occurs above the dentate line.62. Case report
A 66-year-old man presented with a history of recurrent
bleeding from the rectum, a need to strain on defecation,
and perianal pain for the last 3 consecutive months .The
patient was neither diabetic nor hypertensive and had no
history of constipation, altered bowel habits, weight loss,
jaundice, or loss of appetite. He was diagnosed with pro-
lapsed hemorrhoids for which a hemorrhoidectomy was
performed in a peripheral hospital under spinal anesthesia.
His postoperative period was uneventful and no histopath-
ological examination of the excised hemorrhoidal tissues
was carried out. He continued to have recurrent bleeding
and perianal pain and a protruding mass was seen 1 month
after surgery. The patient was examined and there was avisible exophytic growth protruding outside the anal verge,
overlain with blackish spots (Fig. 1A).
On proctoscopy, a blackish growth was seen interiorly
below the dentate line, involving two-thirds of the
circumference of the anal canal and measuring 3  3 cm,
with fresh bleeding on touch. The patient’s hemoglobin was
9 gm%, and his kidney function and liver function tests were
normal. A punch biopsy sample was taken from the growth
and this showed sheets of round to oval cells with promi-
nent nucleoli and cytoplasmic pleomorphism (perivascular)
with marked intracytoplasmic pigmentation (Fig. 1B). No
immunohistochemistry was performed as this was not
available in our institution. Ultrasonography showed mul-
tiple intrahepatic mixed echogenic lesions with central
necrosis (Fig. 1C). Pelvic and abdominal magnetic reso-
nance imaging showed diffuse circumferential wall thick-
ening of the distal rectum and anal canal with nearly
complete obliteration of the lumen, along with perirectal,
presacral, and bilateral inguinal lymph node enlargement
Figure 2 (A) MRI of pelvis showed luminal obstruction of the anal canal in axial and coronal views (arrow). (B) Abdominal MRI
showed metastatic lesions in the liver.
76 T.A. Mala et al.and metastasis to the liver. The mesorectal fascia was
normal and no local infiltration of the tumor was seen
(Fig. 2A and B). The patient was advised to have a co-
lostomy, but he declined and was then referred to an
oncologist for further management. The patient received
both chemotherapy and radiotherapy, but the response was
very poor and he died 2 months later from massive rectal
bleeding.
3. Discussion
Anorectal melanoma is a rare, but very aggressive, tumor
which is more common in women.3,6 It usually affects
women in the 5th or 6th decade of life and presents with
rectal bleeding, pain, or altered bowel habits. Our patient
was a 66-year-old man who presented with a perianal mass,
bleeding from the rectum, and perianal pain with painful
defecation and a sense of incomplete evacuation. Large
series of patients have shown that the 5-year survival rate
for this disease is less than 20%.7
This tumor accounts for 4% of anorectal malignancies
other than adenocarcinoma.1 The features in the early
stage resemble those of hemorrhoids and there is therefore
a tendency for diagnosis to be delayed. This occurred in our
patient, who was misdiagnosed with prolapsed hemor-
rhoids, for which he underwent an operation. Nearly 60% of
patients have metastasis at the time of diagnosis. Previous
studies have not shown any difference in survival rate be-
tween patients treated with wide local excision and those
with abdomino-perineal resection. On histological exami-
nation, the presence of protein S-100, melanoma antigen
HMB-45, and Melan-A expression are strongly suggestive of
melanoma. Irrespective of the surgical treatment, the
prognosis is usually grave and the overall survival time is
10e19 months after diagnosis.2,6 The factors for poor
prognosis include advanced disease at the time of diagnosis
and rich vascularity, which increases the risk of hematog-
enous metastasis. Abdomino-perineal resection may be the
treatment of choice for patients with small lesions of less
than 2 mm.6 Radiotherapy is palliative for locally extensive
tumors and is combined with chemotherapy for metas-
tasis.8 As our patient was in an advanced stage of the dis-
ease, we advised a palliative colostomy, but the patient
declined and was referred to an oncologist for further
management.Studies have shown that BRAF mutations are very un-
common in melanomas arising in sun-protected areas.9
These findings have suggested an association between the
presence of BRAF mutations in malignant melanomas and
exposure to ultraviolet light. Some studies have shown that
adjuvant irradiation after wide local excision improved
local control, which was reflected in a better median sur-
vival compared with wide local excision alone, or even
abdomino-perineal resection without irradiation. Chemo-
therapeutic drugs, such as dacarbazine, carmustine, and
cisplatin, have been used in patients with advanced disease
with improved results.10 The combination of interferon-a,
interleukin-2, and cytotoxic drugs (biochemotherapy) has
been found to be more effective than the use of a single
drug.8 In the future, options may include multimodal
treatment with a combination of chemotherapy, immuno-
therapy, and radiotherapy.4. Conclusion
Rectal bleeding and a painful anal mass, in both male and
female patients, should be thoroughly examined to rule out
the possibility of a malignant melanoma, which is a rare
tumor with a dismal prognosis if diagnosed late. Wide local
excision, if feasible for small early tumors, has not been
shown to be inferior to abdomino-perineal resection. An
early high index of suspicion and histological confirmation
of the tumor by taking a biopsy sample might help in
improving the survival of these patients.References
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